Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 411-414

  Hoogkamp Korstanje, J A A ^a   Dirks Go, S I S ^b   Kabel, P ^c   Manson, W L ^d   Stobberingh, E E ^e   Vreedc, R W ^f   Davies, B I ^g  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c CPRLab   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f General Hospital   (Netherlands)

^g Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; SPARFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL TRIAL; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTICENTER STUDY; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACIDS; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; QUINOLONES; STREPTOCOCCUS PNEUMONIAE;

EID: 0030985784     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.411     Document Type: Article

References (10)

1. Bradbury, F. (1993). Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection. Journal of Antimicrobal Chemotherapy 31, Suppl. E, 153-62.
2. Cooper, M. A., Andrews, J. M., Ashby, J. P., Matthews, R. S. & Wise, R. (1990). In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy 26, 667-76.
3. Bongaerts, G. P. A. & Hoogkamp-Korstanje, J. A. A. (1993). In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against Gram-positive and Gram-negative pathogens from respiratory tract and soft tissue infections. Antimicrobial Agents and Chemotherapy 37, 2017-9.
4. Baker, C. N., Stocker, S. A., Culver, D. H. & Thornsberry, C. (1991). Comparison of the Etest to agar dilution, broth micro-dilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. Journal of Clinical Microbiology 29, 533-8.
5. Skulnick, M., Small, G. W., Lo, P., Patel, M. P., Porter, C. R., Low, D. E., Matsumura, S. et al. (1995). Evaluation of accuracy and reproducibility of Etest for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone. Journal of Clinical Microbiology 33, 2334-7.
6. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 883-8.
7. Piddock, L. J. V. (1994). New quinolones and Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 38, 163-9.
8. Jorgensen, J. H., Howell, A. W. & Maher, L. A. (1991). Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the Etest. Journal of Clinical Microbiology 29, 109-14.
9. Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J. & Fernandes, P. B. (1988). Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy 32, 1710-9.
10. Neal, T. J., O'Donoghue, M. A. T., Ridgway, E. J. & Allen, K. D. (1992). In-vitro activity of ten antimicrobial agents against penicillin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 30, 39-46.